Sweden Holds Strong Position in Biotechnology and in Life Sciences
Stockholm - As a result of a number of scientific breakthroughs in basic research, biotechnology and medicine are among the fields that have developed most rapidly in recent years. The benefits of these developments are manifold, not least in biomedicine and health care. Modern life sciences have given us tools that enable us to do things previously thought impossible. Sweden holds a strong position in biotechnology and the life sciences. In the past ten years, we have doubled the annual number of people taking their PhDs.
According to a recent article in the British medical journal The Lancet, Sweden has the highest per capita production in the world of scientific publications in medicine. When measuring citations per article, Sweden is also among the top five countries in this area. In the last few years, a new entrepreneurial approach has emerged in the Swedish life science community. Many small new research-based companies have sprung from academic research. According to a report published by the EU Commission, Sweden has the fourth largest biotechnology industry in Europe in absolute numbers, after Germany, the United Kingdom and France. Since biotechnology is expected to be an increasingly significant area of economic development in the next few decades, this bodes well for the future. There are many of us who believe that modern biotechnology and medicine have the potential to improve people's health and their quality of life. In my opinion, present generations have a great responsibility to take advantage of the opportunities afforded by the new technology, and to use them responsibly and in harmony with society's basic values.
Sweden has a strong science base for biotechnology and medicine. More resources will be invested in research in the years to come and medicine and the life sciences will be given priority. Such investments lay the foundation for future industrial development in the Swedish biotechnology sector.